✦ LIBER ✦

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

✍ Scribed by Vasey, P A; Atkinson, R; Osborne, R; Parkin, D; Symonds, R; Paul, J; Lewsley, L; Coleman, R; Reed, N S; Kaye, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCOTROC 2B: feasibility of carboplatin f

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

A phase II study of sequential docetaxel

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB

Phase II study of carboplatin followed b

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

A phase II feasibility study of carbopla

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

A Multicenter Phase II Study of Docetaxe

✍ Takashi Ishikawa; Satoru Shimizu; Masaaki Inaba; Taro Asaga; Kiyohumi Katayama; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 554 KB